Pfizer awarded $1.96B Army contract modification for Paxlovid

Pfizer was awarded a $1.96B modification to a contract for the oral therapeutic Paxlovid. Work will be performed in New York, New York, with an estimated completion date of December 31, 2028. FY21 Coronavirus Preparedness Response and Relief Supplemental Appropriations Act funds in the amount of $1.96B were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.